Brief: Xeris Biopharma Reports Q1 2023 Financial Results
09/05/2023 12:28
May 9 (Reuters) - Xeris Biopharma Holdings Inc XERS.O :
* XERIS BIOPHARMA REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* XERIS BIOPHARMA HOLDINGS INC - ENDED Q1 2023 WITH $95.1M
IN
CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS
* XERIS BIOPHARMA HOLDINGS INC - AFFIRMS 2023 GUIDANCE
Source text for Eikon: ID:nBw1FCT68a
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest